Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
CEACAM1 encodes a member of the carcinoembryonic antigen (CEA) gene family, which belongs to the immunoglobulin superfamily. Additionally we are shipping Carcinoembryonic Antigen-Related Cell Adhesion Molecule 1 (Biliary Glycoprotein) Proteins (32) and Carcinoembryonic Antigen-Related Cell Adhesion Molecule 1 (Biliary Glycoprotein) Kits (20) and many more products for this protein.
Showing 10 out of 229 products:
Human Monoclonal CEACAM1 Primary Antibody for cELISA, FACS - ABIN108725
Sémiramoth, Gleizes, Turbica, Sandré, Gorges, Kansau, Servin, Chollet-Martin: Escherichia coli type 1 pili trigger late IL-8 production by neutrophil-like differentiated PLB-985 cells through a Src family kinase- and MAPK-dependent mechanism. in Journal of leukocyte biology 2009
Show all 12 references for ABIN108725
Human Monoclonal CEACAM1 Primary Antibody for EIA, FACS - ABIN114594
Hammarström: The carcinoembryonic antigen (CEA) family: structures, suggested functions and expression in normal and malignant tissues. in Seminars in cancer biology 1999
Show all 11 references for ABIN114594
Mouse (Murine) Monoclonal CEACAM1 Primary Antibody for FACS - ABIN2663557
Hemmila, Turbide, Olson, Jothy, Holmes, Beauchemin: Ceacam1a-/- mice are completely resistant to infection by murine coronavirus mouse hepatitis virus A59. in Journal of virology 2004
Show all 6 references for ABIN2663557
Human Polyclonal CEACAM1 Primary Antibody for EIA, FACS - ABIN616012
Oliveira-Ferrer, Tilki, Ziegeler, Hauschild, Loges, Irmak, Kilic, Huland, Friedrich, Ergün: Dual role of carcinoembryonic antigen-related cell adhesion molecule 1 in angiogenesis and invasion of human urinary bladder cancer. in Cancer research 2004
Show all 3 references for ABIN616012
Human Polyclonal CEACAM1 Primary Antibody for EIA, FACS - ABIN616010
Kilic, Oliveira-Ferrer, Neshat-Vahid, Irmak, Obst-Pernberg, Wurmbach, Loges, Kilic, Weil, Lauke, Tilki, Singer, Ergün: Lymphatic reprogramming of microvascular endothelial cells by CEA-related cell adhesion molecule-1 via interaction with VEGFR-3 and Prox1. in Blood 2007
Show all 3 references for ABIN616010
Human Monoclonal CEACAM1 Primary Antibody for FACS - ABIN4897487
Gebauer, Wicklein, Tachezy, Grob, Steinemann, Manukjan, Göhring, Schlegelberger, Maar, Izbicki, Bockhorn, Schumacher: Establishment and Characterization of a Pair of Patient-derived Human Non-small Cell Lung Cancer Cell Lines from a Primary Tumor and Corresponding Lymph Node Metastasis. in Anticancer research 2016
our data show that human and bovine CEACAM1 can both inhibit NK-cell cytotoxicity although they differ in their intracellular signaling motifs
Data from cultured aortic endothelial cells suggest that CEACAM1 is involved in regulation of vascular endothelial cell reactions to oxidative stress/lipid peroxidation and in regulation of nitric oxide production in large vessels such as aorta.
This data represents the first report of a functional link between CEACAM1 and the VEGFR2 (show KDR Antibodies)/Akt (show AKT1 Antibodies)/eNOS (show NOS3 Antibodies)-mediated vascular permeability pathway.
CEACAM1 has two alleles and serves as a pathogen receptor in cattle.
CEACAM1 exacerbates hypoxic cardiomyocyte injury and post-infarction cardiac remodeling by enhancing cardiomyocyte mitochondrial dysfunction and endoplasmic reticulum stress-induced apoptosis.
The increase in total fat mass in Cc1 (show RB1CC1 Antibodies)(-/-) mice is mainly attributed to hyperphagia and reduced spontaneous physical activity. Although the contribution of the loss of CEACAM1 from anorexigenic proopiomelanocortin (show POMC Antibodies) neurons in the arcuate nucleus is unclear, leptin (show LEP Antibodies) resistance and elevated hypothalamic fatty-acid synthase (show FASN Antibodies) activity could underlie altered energy balance in these mice.
Ceacam1 is essential for normal integrin aIIbb3-mediated platelet function; the disruption of mouse Ceacam1 induced moderate integrin aIIbb3-mediated functional defects.
hepatic CEACAM1 expression at fasting is mediated by Pparalpha (show PPARA Antibodies)-dependent mechanisms.
Gram-positive bacteria promote the mRNA expression of CEACAM1 or CEACAM20 in the small intestine. Inflammatory cytokines or butyrate likely participates in such effects of commensal bacteria.
CEACAM1 is a crucial regulator of B-cell survival, influencing B-cell numbers and protective antiviral antibody responses
High-fat diet amplifies the permissive effect of Ceacam1 deletion on renal expression of all renin (show REN Antibodies)-angiotensin system components, PI3K phosphorylation, inflammation, and fibrosis.
Ceacam1L acts as a crucial factor in glioblastoma-initiating cell maintenance and tumorigenesis by activating c-Src (show SRC Antibodies)/STAT3 (show STAT3 Antibodies) signaling. Monomers of the cytoplasmic domain of Ceacam1L bound to c-Src (show SRC Antibodies) and STAT3 (show STAT3 Antibodies) and induced their phosphorylation.
CEACAM1 levels in the liver were reduced in prenatally stressed diet-induced obesity offspring after the high fat diet challenge, suggesting that preexisting genetic predisposition combined with prenatal stress increases the risk for obesity in adulthood.
high-fat diet reduced hepatic CEACAM1 expression and that overexpressing CEACAM1 in liver curtailed diet-induced metabolic abnormalities by protecting hepatic insulin (show INS Antibodies) clearance.
CEACAM1 mediates bacterial adherence and transcellular transcytosis.
CEACAM1 might play an important role in ovarian tumor progression, especially in tumor metastasis
Osteosarcoma patients with higher CEACAM1 had relatively lower survival compared to those with low CEACAM1 and high serum CEACAM1 level was an independent prognostic factor for osteosarcoma
serum CEACAM1 is elevated over time in progressive melanoma patients who fail to respond to immunotherapy as opposed to responders and stable disease patients.
an MITF (show MITF Antibodies)-CEACAM1 axis is suggested as a potential determinant of melanoma progression.
Collectively, these data suggest that vIL (show VIL1 Antibodies)-6 modulates endothelial cell migration by upregulating the expression of cellular factors, including CEACAM1.
Taken together, our results demonstrate a systematic down-regulation of CEACAM1 in breast cancer and suggest that a strategy to restore CEACAM1 expression may be helpful for the treatment of breast cancer.
Elevated carcinoembryonic antigen (show CEACAM5 Antibodies) expression is associated with recurrence for patients after resection for colorectal liver metastases.
Serum concentrations of CEACAM1 may serve as a useful indicator for the presence of breast cancer
High Carcinoembryonic Antigen (show CEACAM5 Antibodies) expression is associated with colon and stomach cancer.
This gene encodes a member of the carcinoembryonic antigen (CEA) gene family, which belongs to the immunoglobulin superfamily. Two subgroups of the CEA family, the CEA cell adhesion molecules and the pregnancy-specific glycoproteins, are located within a 1.2 Mb cluster on the long arm of chromosome 19. Eleven pseudogenes of the CEA cell adhesion molecule subgroup are also found in the cluster. The encoded protein was originally described in bile ducts of liver as biliary glycoprotein. Subsequently, it was found to be a cell-cell adhesion molecule detected on leukocytes, epithelia, and endothelia. The encoded protein mediates cell adhesion via homophilic as well as heterophilic binding to other proteins of the subgroup. Multiple cellular activities have been attributed to the encoded protein, including roles in the differentiation and arrangement of tissue three-dimensional structure, angiogenesis, apoptosis, tumor suppression, metastasis, and the modulation of innate and adaptive immune responses. Multiple transcript variants encoding different isoforms have been reported, but the full-length nature of all variants has not been defined.
carcinoembryonic antigen-related cell adhesion molecule 1
, carcinoembryonic antigen-related cell adhesion molecule 8
, CEA-related cell adhesion molecule 1
, biliary glycoprotein 1
, biliary glycoprotein D
, carcinoembryonic antigen 1
, carcinoembryonic antigen 7
, hepatitis virus (MHV-4) susceptibility
, hepatitis virus receptor
, murine hepatitis virus receptor
, CD66a antigen
, antigen CD66
, ATP-dependent taurocolate-carrier protein
, C-CAM 105
, CEA-related cell adhesion molecule 1 (bone gamma-carboxyglutamic acid (Gla) protein) (osteocalcin)
, bone gamma-carboxyglutamic acid (Gla) protein
, cell-CAM 105